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Abstract
The bioenergetic needs of aerobic cells are met principally through the action of the F1F0 ATP synthase, which catalyzes ATP synthesis
during oxidative phosphorylation. The catalytic unit of the enzyme (F1) is a multimeric protein of the subunit composition a3h3gyq. Our
work, which employs the yeast Saccharomyces cerevisiae as a model system for studies of mitochondrial function, has provided evidence
that assembly of the mitochondrial a and h subunits into the F1 oligomer requires two molecular chaperone proteins called Atp11p and
Atp12p. Comprehensive knowledge of Atp11p and Atp12p activities in mitochondria bears relevance to human physiology and disease as
these chaperone actions are now known to exist in mitochondria of human cells.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The ATP synthase of mitochondrial, chloroplast, and
bacterial membranes catalyzes ATP synthesis coupled to
respiration [1,2]. The catalytic unit of the enzyme (F1
component) is an oligomer of five different subunits that
are present in the stoichiometric ratio, a3h3gyq. The subunit
composition of the integral membrane component (F0) of
the ATP synthase ranges from the relatively simple form
found in bacteria, in which there are only three types of
subunits (called a, b, and c, see Ref. [3]), to the highly
complex mitochondrial form, which may have as many as
10–12 different types of subunits [4,5].
Themitochondrial ATP synthase does not self-assemble in
vivo. Work with respiratory deficient strains of Saccharomy-
ces cerevisiae has identified three proteins that serve chaper-
one-type functions during assembly of the enzyme under
normal growth conditions; Atp10p is required for F0 assem-
bly [6], while Atp11p and Atp12p both mediate formation of
the F1 oligomer [7]. Another yeast protein, Fmc1p, has been
shown to be required for F1 assembly in cells grown at
elevated temperatures; interestingly, the deletion of Fmc1p
function can be rescued by an additional copy of the gene for
Atp12p [8]. The F1F0 assembly factors are not members of
themajor protein chaperone families (e.g. Hsp70, Hsp60) that
service a broad range of substrates [9]. Instead, the actions of
Atp10p, Atp11p, and Atp12p all appear to be limited to the
biogenesis pathway of the ATP synthase. Of these proteins,
Atp11p and Atp12p have been studied most extensively. In
the absence of either Atp11p or Atp12p, both F1 a and h
subunits accumulate in aggregated form inside mitochondria
[7]. Aggregation of the h subunit occurs also in strains that
are simply deleted for the a subunit and the a subunit
aggregates in a h subunit null strain [7]. In contrast, the
solubility of the a and h subunits is not impaired significantly
in g [10], y [11], or q [12] disruption strains. The favored
interpretation of these observations is that the non-productive
side reaction of a and/or h subunit aggregation prevails only
under conditions in which the a3h3 hexamer cannot be
formed, either because one of the partner subunits is missing,
or because an assembly factor protein (i.e. Atp11p or Atp12p)
is missing whose action is to protect the F1 proteins from
forming dead-end complexes. This article summarizes what
is known about the chaperone actions of Atp11p and Atp12p
in the biogenesis pathway of yeast mitochondrial F1.
2. Domain structure of Atp11p and of Atp12p
Atp11p and Atp12p are nuclear gene products that are
targeted to the mitochondrial matrix via leader sequences
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(Fig. 1, LS) present at the amino terminus of the initial
translation products [13,14]. The estimated start site for
mature Atp11p is Glu40 [15] and for mature Atp12p is Gly31
[16]. Deletion analysis has disclosed the largest spans of N-
terminal or C-terminal sequences that can be removed from
the mature Atp11p or Atp12p proteins without completely
abolishing their action in F1 assembly in vivo. Such work
has revealed that the functional domain of Atp11p lies
within the region between Asp112 and Arg183 (Fig. 1, FD,
upper panel) [17]. In Atp12p, a minimal sequence that can
be designated as the functional domain maps to the region
between Asn181 and Val306 in the carboxyl half of the
protein (Fig. 1, FD, lower panel), although the mutant
protein that terminates with Val306 supports only a very
low level of mitochondrial F1 assembly in vivo, and is
notably deficient for protein–protein interactions mitochon-
dria [16]. Such observations suggest that the terminal 18
amino acids (Asp307–Gln325) constitute a separate oligome-
rization domain (Fig. 1, OD) that is dispensable, but not
without significant consequences with respect to Atp12p
activity.
3. Chaperone actions of Atp11p and Atp12p defined
The use of affinity resins to pull down artificially tagged
forms of the F1 chaperones, coupled with studies that
employed the yeast two-hybrid assay as additional means
to identify protein–protein interactions, has shown that
Atp11p binds selectively to the h subunit of F1 [18] and
that Atp12p binds selectively to the a subunit of F1 [19].
The two-hybrid screen further provided the information that
the binding determinants for Atp11p in the h subunit, and
those for Atp12p in the a subunit, are located in the adenine
nucleotide binding domains (NBD) of the F1 proteins. With
respect to the NBDs of unassembled F1 a and h subunits,
the regions considered most likely to promote aggregation
of the free form of the subunit are the hydrophobic sequen-
ces that will ultimately be sequestered at subunit interfaces
in the a3h3 structure, as nature did not intend such sequen-
ces to be exposed to aqueous solvent. On the basis of
contributions made by amino acid residues of the chaperone
binding domains in the a and h subunits to the interaction
energies in F1 of each a subunit with an adjacent h subunit,
and of each h subunit with an adjacent a subunit, a model
for Atp11p, Atp12p-mediated assembly of the F1 oligomer
has been proposed (Fig. 2, see also Ref. [19]). In this model,
Atp12p binds to the unassembled F1 a subunit at the pre-
interface surface that will ultimately contribute to a non-
catalytic site (NCS) with a neighboring h subunit, while
Atp11p binds to the unassembled F1 h subunit at the pre-
interface surface that forms a catalytic site (CS) with an
adjacent a subunit in the assembled enzyme.
The fact that Atp11p and Atp12p are each selective for
binding only one of the two F1 subunits raises the question
of why both a and h subunits accumulate as aggregated
proteins in yeast cells lacking only one of the two chaper-
ones [7]. This issue can be resolved on the basis of protein
stoichiometries. Atp11p and Atp12p are present in the
mitochondria at a concentration that is at least 100-fold
lower than the steady-state level of F1 proteins [15,19],
which is reasonable in view of the fact that the F1 subunits
are assembled into the oligomer as soon as they are
imported from the cytoplasm; in other words, there are no
pools of unassembled a and h subunits in the mitochondrial
matrix [20]. When either Atp11p or Atp12p is absent, one of
the two subunits aggregates as a direct consequence of the
missing chaperone protein. However, under such conditions,
the steady-state level of the ‘‘partner’’ F1 subunit builds and
eventually far exceeds the level of the remaining chaperone.
Fig. 1. Domain maps of Atp11p and Atp12p. LS, leader sequence; FD,
functional domain; OD, oligomerization domain.
Fig. 2. Atp11p, Atp12p-mediated F1 assembly. CS, catalytic site; NCS,
noncatalytic site.
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Hence, even though Atp11p and Atp12p only interact
directly with one type of F1 subunit, each chaperone is
perceived to ultimately control the fate of both the a and the
h subunits in mitochondria.
4. Evidence that hydrophobic residues are a key element
of Atp11p chaperone action
Yeast Atp11p is overproduced as a soluble recombinant
protein in bacteria and can be purified to homogeneity [15].
The marked insolubility of purified mitochondrial F1 pro-
teins has made it impossible to examine the action of
Atp11p with its natural substrate in vitro (S. Ackerman
and D. Sheluho, unpublished observations). Instead, we
have employed insulin as a surrogate substrate for studies
that analyze Atp11p chaperone action in vitro [21]. Aggre-
gation of the insulin B chain occurs concomitant with
reduction of the disulfide bonds in the parent protein [22].
The ability to induce this reaction under controlled con-
ditions has been exploited to study the chaperone action of
several proteins including a-crystallin [23], Hsp90 [24], and
SecB [25]. At equimolar concentration to insulin, Atp11p
provides 70% protection against aggregation of the B chain,
while a control protein (ribonuclease A) has no effect [21].
The nonpolar character of the Atp11p functional domain
noted in earlier work [17] suggested that the activity of this
protein might be mediated through hydrophobic binding
interactions. To investigate this issue, we employed the
environment-sensitive fluorescent dye 1,1V-bis(4-anilino-5-
napththalenesulfonic acid) (bis-ANS); bis-ANS has been
used extensively to probe hydrophobic surfaces in a number
of proteins [26–30]. Fluorescence from bis-ANS is barely
detectable in aqueous buffer, while the inclusion of Atp11p
in the mixture effects a several-fold increase in quantum
yield and blue-shift of the emission that is highly diagnostic
of bis-ANS binding to an accessible hydrophobic surface of
the protein [21]. bis-ANS also quenches fluorescence from
Atp11p tryptophans, giving further testimony to the fact that
the dye forms a complex with the protein [21]. Titration
studies indicate that f 3 moles of bis-ANS bind per mole
of Atp11p at saturation [21]. Interestingly, the binding data
are sigmoidal, indicative of positive cooperativity, which
suggests that Atp11p may undergo a change in conforma-
tion upon binding bis-ANS in a manner similar to what has
been observed when the dye binds to DnaK [26] and to the
apical domain of GroEL [27]. While we do not know the
nature of any putative conformational changes induced by
bis-ANS, the spectral and solubility properties of Atp11p in
the presence of stoichiometric amounts of the dye do not
reveal a gross perturbation of the protein structure. How-
ever, it is clear that the protein function is greatly compro-
mised by bis-ANS since at equimolar dye/protein
concentration, the chaperone action of the Atp11p is vir-
tually eliminated (Fig. 3) [21]. The inability of an Atp11p/
bis-ANS complex to provide significant protection against
aggregation of the reduced insulin B chain provides evi-
dence that the hydrophobic surface in Atp11p to which the
dye binds is important for the chaperone activity of the
protein.
5. Atp11p and Atp12p actions are conserved from yeast
to humans
In recent years, we have identified protein sequences
from a number of eukaryotic organisms that are homologous
with Atp11p and Atp12p of budding yeast [31,32]. The
alignment of S. cerevisiae Atp11p with the homologous
proteins of Schizosaccharomyces pombe, Drosophila
yakuba, and Homo sapiens (Fig. 4A) indicates 23% overall
similarity and 9% identity amongst the sequences. The
alignment of six homologous Atp12p protein sequences
(Fig. 4B) indicates 12.7% overall similarity and 4.6%
identity. Pairwise analysis yields much higher values with
at least 40% similarity and 20% identity in most cases. We
isolated a full-length cDNA that codes for human Atp12p
and showed that it complements a yeast Datp12 disruption
strain, and that the product of the cDNA interacts preferen-
tially with human F1 a subunit versus human F1 h subunit
in a two-hybrid screen [32]. A near-complete human ATP11
cDNA that encodes a form of the protein deficient for only
f 25 amino acids from the amino terminus does not
complement a yeast Datp11 deletion mutant; however, the
product of this cDNA was shown to bind to the human h
subunit, and not to the human a subunit, in a two-hybrid
assay [32]. The substrate selectivity exhibited by human
Atp11p and Atp12p suggests that these proteins function in
a manner that is analogous to their yeast counterparts.
Fig. 3. Effect of bis-ANS binding on the chaperone action of Atp11p. Insulin
was reduced with DTTand assayed for aggregation as described in Ref. [21].
Circles, insulin alone; squares, insulin plus Atp11p/bis-ANS complex
(protein complex prepared by incubating Atp11p and bis-ANS at 1:1 molar
ratio, see Ref. [21]); triangles, insulin plus unliganded Atp11p. Before
addition to the assay, the Atp11p/bis-ANS sample and the unligandedAtp11p
sample were each passed through a G25 centrifuge column. The
concentrations of insulin, Atp11p, and bis-ANS were each 34 AM.
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Human ATP11 spans 24 kb in 9 exons and maps to 1p32.3–
p33, while ATP12 contains = 8 exons and localizes to
17p11.2 [32]. Both genes are expressed in a wide range of
tissues, which suggests that Atp11p and Atp12p are essen-
tial housekeeping proteins of human cells.
6. Conclusion
To date, our laboratory has provided information about
primary sequence elements in Atp11p and Atp12p that are
functionally relevant and we have identified the specific
Fig. 4. Alignment of homologous Atp11p (A) and Atp12p (B) proteins. Sequences were aligned with CLUSTALW. SCER (Saccharomyces cerevisiae); SPOM
(Schizosaccharomyces pombe); DYAK (Drosophila yakuba); DMEL (Drosophila melanogaster); HSAP (Homo sapiens); CELE (Caenorhabditis elegans);
RCAP (Rhodobacter capsulatus). Shading indicates identical and physicochemically similar amino acids; identities are further highlighted in bold. The boxes
indicate the estimated start of the S. cerevisiae proteins that are generated after cleavage of the targeting peptide. The bars indicate the span of sequence in
Atp11p and in Atp12p that has been assigned as the functional domain in the protein (see Refs. [16,17]).
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binding interactions (Atp11p with F1 h, Atp12p with F1 a)
that define the chaperone activities of these proteins. From
the standpoint of mechanism, a key issue to be resolved is
how Atp11p is exchanged for an a subunit and how Atp12p
is exchanged for a h subunit to complete assembly of the F1
a3h3 oligomer. Of more physiological relevance is to fully
characterize the phenotype that is associated with the loss of
Atp11p or Atp12p function to better understand the type of
disease that might be associated with a deficiency of these
chaperones in human cells.
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